Digital Library
Close Browse articles from a journal
 
   next >>
     Journal description
       All volumes of the corresponding journal
         All issues of the corresponding volume
           All articles of the corresponding issues
                                       Details for article 1 of 27 found articles
 
 
  A novel molecular marker of breast cancer stem cells identified by cell-SELEX method
 
 
Title: A novel molecular marker of breast cancer stem cells identified by cell-SELEX method
Author: Lu, Min
Zhou, Lei
Zheng, Xiaohui
Quan, Yi
Wang, Xiaoli
Zhou, Xinna
Ren, Jun
Appeared in: Disease markers. Section A, Cancer biomarkers
Paging: Volume 15 (2014) nr. 2 pages 163-170
Year: 2014-12-12
Contents: BACKGROUND: Breast cancer stem cells (CSCs) are thought to initiate mammary tumors and render them resistant to anti-cancer therapies. However, there are currently no ideal biomarkers to identify this minority population in breast cancer. OBJECTIVE: To find out the oligonucleotides with high specificity and affinity for mammosphere cells using a high capacity ssDNA library. METHODS: We used the cell-SELEX (systematic evolution of ligands by exponential enrichment process) method. MCF-7 cells were cultured in serum-free media to form mammosphere cells as enriched stem cells, and were used as the positive target cells. The normal breast epithelial MCF-10A and MCF-7sal cells, which are MCF-7 cells treated with Salinomycin, were used as the negative target cells. We collected the ssDNA pools that were bound to positive target cells, and could not bind negative target cells. RESULTS: After 13 rounds of selection, we isolated the MS03 aptamer with high specificity and affinity for mammosphere cells. When compared with CD44^{ + }/CD24^{ - / low} cells, MS03^{ + } cells did not show any significant difference in sphere formation ability in vitro. In addition, 63.3% of MS03 aptamer-selected cells exhibited the CD44^{ +}/CD24^{ - / low} phenotype. Because the MS03 aptamer is synthesized easily and non-immunogenic, it is much more flexible than CD44/CD24 as a breast CSC biomarker. CONCLUSIONS: The MS03 aptamer may become a promising molecular probe during diagnostic and therapeutic applications in breast cancer.
Publisher: IOS Press
Source file: Elektronische Wetenschappelijke Tijdschriften
 
 

                             Details for article 1 of 27 found articles
 
   next >>
 
 Koninklijke Bibliotheek - National Library of the Netherlands